Lilly's UK Vote of Confidence
Executive Summary
Lilly's recent decision to beef up its UK research and manufacturing facilities is a bright spot in an otherwise bleak picture of pharmaceutical investment in Europe. But rather than providing encouraging news for Europe in general, the move may simply highlight what sets the UK apart from its fellow Europeans.